These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11544007)

  • 1. Managing the highly sensitized transplant recipient and B cell tolerance.
    Baid S; Saidman SL; Tolkoff-Rubin N; Williams WW; Delmonico FL; Cosimi AB; Pascual M
    Curr Opin Immunol; 2001 Oct; 13(5):577-81. PubMed ID: 11544007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
    Cosimi AB; Sachs DH; Sykes M; Kawai T
    Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
    Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presensitization accelerates chronic allograft rejection in a heterotopic rat tracheal allograft model with immunosuppression.
    Okumoto T; Yamane M; Sano Y; Aoe M; Date H; Shimizu N
    Transpl Immunol; 2007 Jun; 17(4):249-54. PubMed ID: 17493527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM; Ozawa M; Verbanac KM; Catrou P; Haisch CE; Terasaki PI
    Clin Transpl; 2006; ():241-53. PubMed ID: 18365382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
    Leone JP; Bowers V; Baliga R; Sanders C; LeFor W; Becker D; Thompson D; Resto-Ruiz S; Lopez-Cepero M
    Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased lung allograft failure in patients with HLA-specific antibody.
    Girnita AL; McCurry KR; Zeevi A
    Clin Transpl; 2007; ():231-9. PubMed ID: 18637473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidden perils in a highly sensitized kidney transplant recipient.
    Ford S; Summers S; Cantwell L; Mulley W
    Nephrology (Carlton); 2012 Apr; 17 Suppl 1():9-11. PubMed ID: 22497647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-idiotypic antibodies from highly sensitized patients stimulate B cells to produce anti-HLA antibodies.
    Hack N; Angra S; Friedman E; McKnight T; Cardella CJ
    Transplantation; 2002 Jun; 73(12):1853-8. PubMed ID: 12131677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance induction: hematopoietic chimerism.
    Kawai T; Sachs DH
    Curr Opin Organ Transplant; 2013 Aug; 18(4):402-7. PubMed ID: 23838644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinations of anti-LFA-1, everolimus, anti-CD40 ligand, and allogeneic bone marrow induce central transplantation tolerance through hemopoietic chimerism, including protection from chronic heart allograft rejection.
    Metzler B; Gfeller P; Bigaud M; Li J; Wieczorek G; Heusser C; Lake P; Katopodis A
    J Immunol; 2004 Dec; 173(11):7025-36. PubMed ID: 15557200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
    Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
    Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual literature review of donor-specific HLA antibodies after organ transplantation.
    Kaneku H
    Clin Transpl; 2011; ():311-8. PubMed ID: 22755424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative treatment of a presensitized kidney transplant recipient with donor-derived transplant acceptance-inducing cells.
    Hutchinson JA; Roelen D; Riquelme P; Brem-Exner BG; Witzke O; Philipp T; Matthäi M; Gövert F; Claas FH; Westphal E; Kunzendorf U; Geissler EK; Fändrich F
    Transpl Int; 2008 Aug; 21(8):808-13. PubMed ID: 18573140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in understanding humoral rejection in kidney transplantation: implications for patient management.
    Pascual MA; Crespo M; Tolkoff-Rubin N
    Nefrologia; 2001; 21(4):327-31. PubMed ID: 11816504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttransplant immunosuppression in highly sensitized patients.
    Akalin E
    Contrib Nephrol; 2009; 162():27-34. PubMed ID: 19001811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of low levels of alloantibody after desensitization in crossmatch-positive living-donor kidney transplantation.
    Gloor JM; DeGoey S; Ploeger N; Gebel H; Bray R; Moore SB; Dean PG; Stegall MD
    Transplantation; 2004 Jul; 78(2):221-7. PubMed ID: 15280682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thoracic organ transplantation: laboratory methods.
    Patel JK; Kobashigawa JA
    Methods Mol Biol; 2013; 1034():127-43. PubMed ID: 23775735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-specific alloantibodies and renal graft outcome.
    Sumitran-Holgersson S
    Nephrol Dial Transplant; 2001 May; 16(5):897-904. PubMed ID: 11328893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.